These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16209383)

  • 1. Usefulness of a rapid human immunodeficiency virus-1 antibody test for the management of occupational exposure to blood and body fluid.
    Landrum ML; Wilson CH; Perri LP; Hannibal SL; O'Connell RJ
    Infect Control Hosp Epidemiol; 2005 Sep; 26(9):768-74. PubMed ID: 16209383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
    Doyle NM; Levison JE; Gardner MO
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
    Wesolowski LG; MacKellar DA; Facente SN; Dowling T; Ethridge SF; Zhu JH; Sullivan PS;
    AIDS; 2006 Aug; 20(12):1661-6. PubMed ID: 16868448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the performance of OraQuick ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK.
    Zelin J; Garrett N; Saunders J; Warburton F; Anderson J; Moir K; Symonds M; Estcourt C;
    Int J STD AIDS; 2008 Oct; 19(10):665-7. PubMed ID: 18824617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-positive oral fluid rapid HIV tests--New York City, 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(24):660-5. PubMed ID: 18566566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies.
    Delaney KP; Branson BM; Uniyal A; Kerndt PR; Keenan PA; Jafa K; Gardner AD; Jamieson DJ; Bulterys M
    AIDS; 2006 Aug; 20(12):1655-60. PubMed ID: 16868447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India.
    Pant Pai N; Joshi R; Dogra S; Taksande B; Kalantri SP; Pai M; Narang P; Tulsky JP; Reingold AL
    PLoS One; 2007 Apr; 2(4):e367. PubMed ID: 17426815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency department management of occupational exposures: cost analysis of rapid HIV test.
    Kallenborn JC; Price TG; Carrico R; Davidson AB
    Infect Control Hosp Epidemiol; 2001 May; 22(5):289-93. PubMed ID: 11428439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare worker adherence to follow-up after occupational exposure to blood and body fluids at a teaching hospital in Brazil.
    Escudero DV; Furtado GH; Medeiros EA
    Ann Occup Hyg; 2015 Jun; 59(5):566-71. PubMed ID: 25636318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of healthcare workers.
    Puro V; Francisci D; Sighinolfi L; Civljak R; Belfiori B; Deparis P; Roda R; Modestino R; Ghinelli F; Ippolito G
    J Hosp Infect; 2004 Jun; 57(2):179-82. PubMed ID: 15183251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of rapid HIV testing of pregnant women in India.
    Bhore AV; Sastry J; Patke D; Gupte N; Bulakh PM; Lele S; Karmarkar A; Bharucha KE; Shrotri A; Pisal H; Suryawanshi N; Tripathy S; Risbud AR; Paranjape RS; Shankar AV; Kshirsagar A; Phadke MA; Joshi PL; Brookmeyer RS; Bollinger RC
    Int J STD AIDS; 2003 Jan; 14(1):37-41. PubMed ID: 12590791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post exposure prophylaxis following occupational exposure to HIV: a survey of health care workers in Mbeya, Tanzania, 2009-2010.
    Mponela MJ; Oleribe OO; Abade A; Kwesigabo G
    Pan Afr Med J; 2015; 21():32. PubMed ID: 26405468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].
    Kowalska JD; Firlag-Burkacka E; Niezabitowska M; Bakowska E; Ignatowska A; Pulik P; Horban A
    Przegl Epidemiol; 2006; 60(4):789-94. PubMed ID: 17682761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids.
    Branson BM
    AIDS Clin Care; 2004 May; 16(5):39. PubMed ID: 15199863
    [No Abstract]   [Full Text] [Related]  

  • 17. Costs of management of occupational exposures to blood and body fluids.
    O'Malley EM; Scott RD; Gayle J; Dekutoski J; Foltzer M; Lundstrom TS; Welbel S; Chiarello LA; Panlilio AL
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):774-82. PubMed ID: 17564978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA notifications. Oral fluid-based rapid HIV test approved.
    AIDS Alert; 2004 Jun; 19(6):71-2. PubMed ID: 15272453
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry.
    Wang SA; Panlilio AL; Doi PA; White AD; Stek M; Saah A
    Infect Control Hosp Epidemiol; 2000 Dec; 21(12):780-5. PubMed ID: 11140914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers.
    Uslan DZ; Virk A
    J Travel Med; 2005; 12(1):14-8. PubMed ID: 15996462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.